Market capitalization | $760.00k |
Enterprise Value | $2.79m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 3.72 |
P/S ratio (TTM) P/S ratio | 1.01 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 190.70% |
Revenue (TTM) Revenue | $750.00k |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
2 Analysts have issued a Yield10 Bioscience, Inc. forecast:
2 Analysts have issued a Yield10 Bioscience, Inc. forecast:
Dec '23 |
+/-
%
|
||
Net Profit | -14 -14 |
7%
7%
|
|
Depreciation and Amortization | 0.29 0.29 |
56%
56%
|
|
Stock Compensation | 1.59 1.59 |
16%
16%
|
|
Operating Cash Flow | -10 -10 |
12%
12%
|
|
Investments | 0.05 0.05 |
67%
67%
|
|
Dividend Paid | - - |
-
|
|
Free Cash Flow | -10 -10 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
Head office | United States |
CEO | Oliver Peoples |
Employees | 29 |
Founded | 1992 |
Website | www.yield10bio.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.